TMEV VP1 cleavage by proteases may disrupt a major neutralization epitope, potentially explaining the mechanism of viral persistence and altered cytotropism in demyelinating disease.
No takes yet. Share an insight, caveat, or question.
May inform TMEV persistence mechanisms in animal models; leaves open relevance to human demyelinating disease.
Nitayaphan et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: